Video Experimental Relacionado
Updated: Jul 9, 2026
08:07
Preparation of Herbal Medicine: Er-Xian Decoction and Er-Xian-containing Serum for In Vivo and In Vitro Experiments
Published on: May 31, 2017
Plataforma de suministro para fármacos hidrofóbicos: enfoque de pró-droga combinado con múltiples capas
Benjamin Thierry1, Piotr Kujawa, Cathy Tkaczyk
1Department of Biomedical Engineering, McGill University, H3A 2B Montreal, Canada.
Journal of the American Chemical Society
|February 11, 2005
Resumen
Este estudio introduce una nueva plataforma de administración de fármacos que utiliza prodrogas macromoleculares y ensamblaje capa por capa para fármacos hidrofóbicos como el paclitaxel. Este método libera efectivamente el fármaco, causando una muerte significativa de las células cancerosas.
Área de la Ciencia:
- Ciencia de los Biomateriales Ciencia de los Biomateriales.
- Sistemas de suministro de drogas Sistemas de suministro de drogas.
- Nanotecnología La nanotecnología es la nanotecnología.
Sus antecedentes:
- Los fármacos hidrofóbicos, como el paclitaxel, se enfrentan a desafíos en la administración efectiva debido a su mala solubilidad.
- Los prodrogas macromoleculares y el ensamblaje capa por capa (LbL) ofrecen soluciones potenciales para la liberación controlada de fármacos.
Objetivo del estudio:
- Diseñar y caracterizar una nueva plataforma de administración de fármacos para medicamentos hidrofóbicos.
- Para utilizar un pródrogo de éster de hialuronano de paclitaxel con polielectrolitos multicapa ensamblados con LbL.
Principales métodos:
- Síntesis de un pródrogo de éster de hialuronano de paclitaxel.
- Ensamblaje de capas por capas de polielectrolitos multicapa que incorporan el medicamento.
- Caracterización utilizando microbalance de cristal de cuarzo, microscopía de fuerza atómica y espectroscopía UV.
Principales resultados:
- La conjugación de paclitaxel con hialuronano no afectó su actividad.
- Las fracciones de fármacos hidrofóbicos no impidieron la construcción multicapa de LbL.
- La hidrólisis del enlace de éster desencadenó la liberación del fármaco, lo que condujo a una muerte significativa de las células cancerosas.
Conclusiones:
- La plataforma desarrollada proporciona efectivamente medicamentos hidrofóbicos, lo que demuestra el potencial para la terapia del cáncer.
- Este enfoque se puede aplicar a varios sustratos, incluidos coloides, implantes y tejidos, para nuevas estrategias terapéuticas.
Videos de Conceptos Relacionados
01:22Drug Delivery: Miscellaneous Routes
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs through the...
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs through the...
01:28Factors Influencing Drug Absorption: Pharmaceutical Parameters
Solid dosage forms such as tablets and capsules undergo rigorous manufacturing processes to ensure stability and effectiveness. Their dissolution and absorption properties are influenced significantly by the choice of excipients (inactive ingredients that serve various roles in the formulation), and the methodology applied during production. The manufacturing parameters, such as compression force and granulation techniques, significantly affect dissolution rates. Elevated compression forces...
01:19Modified-Release Drug Delivery Systems: Rate-Programmed II
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
01:27Drug Delivery Systems: Different Types
Conventional oral drug products, termed immediate-release (IR) formulations, are engineered to promptly release their active pharmaceutical ingredient (API) upon ingestion, typically in tablets or capsules. This rapid release often results in swift drug absorption and consequent pharmacodynamic effects, although the timing and intensity can vary depending on the drug's properties. Prodrugs within these formulations require metabolic conversion to activate their pharmacodynamic effects,...
01:23Oral Drug Delivery Systems: Introduction
Oral drug delivery is the most common route of administration due to its convenience, cost-effectiveness, and high patient compliance. It enables precise formulation to ensure proper drug dosage and bioavailability. The development of oral dosage forms considers drug properties such as solubility, stability, and absorption to optimize therapeutic efficacy.Tablets, capsules, liquids, and chewable formulations enhance drug stability, mask undesirable tastes, and improve patient experience.
01:11Oral Drug Delivery Systems: Delayed-Release Systems
Delayed-release drug delivery systems are specialized pharmaceutical formulations designed to postpone the release of active compounds until the drug reaches a specific region of the gastrointestinal (GI) tract, typically the intestine. These systems are essential for drugs that may cause gastric irritation, are unstable in acidic environments, or need to exert therapeutic effects locally in the intestinal or colonic regions.The core feature of delayed-release systems is the use of enteric...